Tuesday, January 27, 2026
HomeTagsRead Magazine

Read Magazine

Incyte Provides Regulatory Update on Ruxolitinib Extended-Release Tablets

Incyte announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for ruxolitinib extended-release (XR) tablets, a JAK1/JAK2 inhibitor,...

Cover Whale Partners with TrustedChoice.com to Provide Tailored Coverage Plans to Truck Drivers

Cover Whale Insurance Solutions, Inc., a leading commercial trucking insurance provider and fast-growing insurtech, announces its partnership with TrustedChoice.com, the nation's largest digital marketing...

Lattice Wins 2023 Artificial Intelligence Awards

Lattice Semiconductor, the low power programmable leader, announced that it won two Artificial Intelligence Excellence Awards from The Business Intelligence Group. The Lattice Avant™...

AbbVie Advances Upadacitinib (RINVOQ) to Phase 3 Clinical Trials in Systemic Lupus Erythematosus

AbbVie announced topline results from a Phase 2 study of upadacitinib given alone or as combination therapy (ABBV-599) with a Bruton's Tyrosine Kinase inhibitor (elsubrutinib,...

WIPO Publishes Aquavit’s Methods for Delivering Bioactive Compositions and Formulations to the Skin

Aquavit Pharmaceuticals, Inc. (Aquavit), a biotechnology company focused on the development of a first-of-its-kind microchannel drug delivery technology, announced that the company's technology patent...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics